IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Achilles Therapeutics PL (698)

CUSIP: 00449L102 | GR | 88 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Trium Capital LLP61,506
0.1% of portfolio›$91.0K
Rhumbline Advisers4,480
0.0% of portfolio›$6.6K
Gamma Investing LLC806
0.0% of portfolio›$1.2K
StyleTurnoverLocationFiled
Trium Capital LLP
61,506$91.0K0.1%YieldVery HighLondon, United Kingdom2026-07-16
Rhumbline Advisers
4,480$6.6K0.0%IndexVery LowBoston, MA2026-08-12
Gamma Investing LLC
806$1.2K0.0%IndexVery LowFoster City, CA2026-07-07